Three-dimensional quantitative structure - Activity relationship (QSAR) and receptor mapping of cytochrome P-45014αDM inhibiting azole antifungal agents

Journal of Chemical Information and Computer Sciences

Volumn 39, Issue 2, 1999, Pages 204-210

  Talele, Tanaji T ^a   Kulkarni, Vithal M ^a  

^a UNIVERSITY OF MUMBAI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CYTOCHROME P450; ENZYME INHIBITOR; LANOSTEROL 14 ALPHA-DEMETHYLASE; OXIDOREDUCTASE; PYRROLE DERIVATIVE; STEROL 14ALPHA DEMETHYLASE;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; DRUG DESIGN; ELECTRICITY; STRUCTURE ACTIVITY RELATION;

ANTIFUNGAL AGENTS; AZOLES; BINDING SITES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG DESIGN; ELECTROSTATICS; ENZYME INHIBITORS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OXIDOREDUCTASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033093008     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci9800413     Document Type: Article

References (25)

1. Presented in part at the First Indo-U.S. Workshop on Mathematical Chemistry, Santiniketan, West Bengal, India, January 9-13, 1998.
2. Tafi, A.; Anastassopoulou, J.; Theophanides, T.; Botta, M.; Corelli, F.; Massa, S., Artico, M.; Costi, R.; Di Santo, R., Ragno, R. Molecular Modeling of Azole Antifungal Agents Active Against Candida albicans. 1. A Comparative Molecular Field Analysis Study. J. Med. Chem. 1996, 39, 1227-1235.
3. Hitchcock, C. A.; Dickinson, K.; Brown, S. B.; Evans, E. G. V.; Adams, D. J. Interaction of Azole Antifungal Antibiotics with Cytochrome P-450 Dependent 14 α-Sterol Demethylase Purified from Candida albicans. Biochem. J. 1990, 266, 475-480.
4. 14αDM Purified from Saccharomyces cerevisiae Microsomes. Biochem. Pharmacol. 1987, 36, 229-235.
5. Goldman, R. C.; Klein, L. L. Problems and Progress in Opportunistic Infections. In Annual Reports in Medicinal Chemistry; Bristol, A. J.; Ed.; Academic Press: San Diego, CA. 1994; Vol. 29, pp 155-164.
6. Odds, F. C.; Schmid, J.; Soll, D. R. Epidemiology of Candida infections in AIDS. In Mycoses in AIDS Patients; Vanden Bossche, H., Ed.; Plenum Press: New York, 1990; pp 67-74.
7. Fromtling, R. A. Drugs of the Future 1985, 10, 983-984.
8. Sammes, P. G. In Topics in Antibiotic Chemistry; Sammes, P. G., Ed.; Ellis Horwood Limited: Chichester, 1982; Vol. 6, Chapter 1, pp 22-97.
9. Drugs of the Future 1981, 6, 444-445.
10. Drugs of the Future 1988, 13, 624-626.
11. Benfield, P.; Clissold, S. P. Sulconazole: A Review of its Antimicrobial Activity and Therapeutic use in Superficial Dermatomycoses. Drugs 1988, 35, 143-153.
12. Xavier, R.; Hopkins, S. J. Neticonazole: A New and Highly active imidazole antifungal agent. Drugs of Today 1994, 30, 497-505.
13. Plempel, M.; Regel, E.; Buchel, K. H. Antimycotic Efficacy of Bifonazole in Vitro and in Vivo. Arzneim.-Forsch. 1983, 31, 517-524.
14. Bartoli, J.; Alguero, M.; Boncomte, E.; Forn, J. Synthesis and Antifungal Activity of a Series of Difluorotritylimidazoles. Arzneim.-Forsch. 1992, 42, 832-835.
15. Michel, G. Drugs of Today 1993, 29, 307-310.
16. Golender, V.; Vorpagel, E. In 3D QSAR in Drug Design: Theory, Methods and Applications; Kubinyi, H., Ed.; ESCOM Leiden, 1993; pp 137-149.
17. Van de Waterbeemd, H. In Advanced Computer-Assisted Techniques in Drug Discovery; Van de Waterbeemd, H., Ed.; VCH Publishers: New York, 1994; Vol. 3.
18. INSIGHT II (v. 95.0); Molecular Simulations Inc.: 9685 Scranton Road, San Diego, CA 92121-3752, U.S.A., October 1995.
19. Molecular Simulations Inc., San Diego, CA.
20. 14αDM Inhibiting Azole Antifungals. Drug Design Discovery 1998, 15, 181-190.
21. Good, A. C.; Hodgkin, E. E.; Richards, W. G. The utilization of Gaussian Functions for the Rapid Evaluation of Molecular Similarity. J. Chem. Inf. Comput. Sci. 1992, 32, 188-191.
22. Hariprasad, V.; Kulkarni, V. M. A proposed common spatial pharmacophore and the corresponding active conformations of some peptide leukotriene receptor antagonists. J. Comput.-Aided Mol. Design 1996, 10, 284-292.
23. 1 Dopamine Receptor Agonists: Pharmacophore Assessment and Receptor Mapping. J. Med. Chem. 1996, 39, 285-296.
24. Myers, R. H. In Classical and Modem Regression with Application; PWS-KENT Publishing Company: 1990.
25. Marshal, G. R.; Barry, C. D.; Bosshard, H. E.; Dammkoehler, R. A.; Dunn, D. A. The Conformational Parameter in Drug Design: the Active Analogue Approach. In ACS Symp. Ser. 1979, 112, 205-226.